SEC Form D filing
FibroBiologics, Inc.
Biotech · Series A · Regulation D 506(b) · TX · Filed June 29, 2026
- Offering amount
- $3.0M
- Exemption
- Reg D 506(b)
- Issuer state
- TX
- Filing date
- June 29, 2026
- Signature date
- June 29, 2026
- CIK
- 0001958777
Summary
Auto-generatedFibroBiologics is a clinical-stage biotechnology company developing fibroblast cell therapies. The $3 million offering points to a series-a stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.